Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 52 | $692,577,007 |
| Sells | 2 | $3,807,102 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Nov 2024 17:00 | TYRA | Tyra Biosciences Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 08 Nov 2024 | Purchase | 1,220,681 | 16.25 | 19,836,066 | I |
| 30 Oct 2024 18:12 | SEPN | Septerna Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 28 Oct 2024 | Purchase | 3,828,400 | 18 | 68,911,200 | I |
| 30 Oct 2024 18:12 | SEPN | Septerna Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 28 Oct 2024 | Purchase | 341,600 | 18 | 6,148,800 | I |
| 22 Oct 2024 16:20 | JANX | Janux Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 18 Oct 2024 | Purchase | 1,200,000 | 44.75 | 53,700,000 | I |
| 18 Sep 2024 18:02 | BCAX | Bicara Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 16 Sep 2024 | Purchase | 152,480 | 18 | 2,744,640 | I |
| 18 Sep 2024 18:02 | BCAX | Bicara Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 16 Sep 2024 | Purchase | 1,680,520 | 18 | 30,249,360 | I |
| 13 Aug 2024 17:03 | ANTX | AN2 Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 09 Aug 2024 | Sale | 114,759 | 1.08 | 123,940 | I |
| 13 Aug 2024 17:03 | ANTX | AN2 Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 09 Aug 2024 | Sale | 3,410,335 | 1.08 | 3,683,162 | I |
| 24 Jul 2024 16:27 | ARTV | Artiva Biotherapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 22 Jul 2024 | Purchase | 688,326 | 12 | 8,259,912 | I |
| 24 Jul 2024 16:27 | ARTV | Artiva Biotherapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 22 Jul 2024 | Purchase | 7,645,007 | 12 | 91,740,084 | I |
| 01 Jul 2024 21:29 | ELYM | Eliem Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Jun 2024 | Purchase | 1,059,375 | 3.84 | 4,068,000 | I |
| 01 Jul 2024 21:29 | ELYM | Eliem Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Jun 2024 | Purchase | 11,949,171 | 3.84 | 45,884,817 | I |
| 20 Jun 2024 17:56 | AVTE | Aerovate Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 17 Jun 2024 | Purchase | 928,110 | 1.67 | 1,549,944 | I |
| 04 Apr 2024 16:15 | BOLD | Boundless Bio Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 02 Apr 2024 | Purchase | 15,625 | 16 | 250,000 | I |
| 04 Apr 2024 16:15 | BOLD | Boundless Bio Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 02 Apr 2024 | Purchase | 296,875 | 16 | 4,750,000 | I |
| 29 Mar 2024 17:38 | NKTX | Nkarta Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Mar 2024 | Purchase | 3,000,000 | 10 | 30,000,000 | I |
| 27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Mar 2024 | Purchase | 505,954 | 9.79 | 4,953,290 | I |
| 27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 25 Mar 2024 | Purchase | 437,600 | 9.06 | 3,964,656 | I |
| 27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 26 Mar 2024 | Purchase | 457,745 | 9.55 | 4,371,465 | I |
| 25 Mar 2024 20:48 | LENZ | LENZ Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 21 Mar 2024 | Purchase | 64,971 | 15.03 | 976,514 | I |
| 25 Mar 2024 20:48 | LENZ | LENZ Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 21 Mar 2024 | Purchase | 933,038 | 15.03 | 14,023,561 | I |
| 06 Mar 2024 17:40 | ETNB | 89bio Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 04 Mar 2024 | Purchase | 1,350,000 | 15.35 | 20,722,500 | I |
| 13 Feb 2024 16:33 | PEPG | PepGen Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 09 Feb 2024 | Purchase | 2,557,593 | 10.64 | 27,212,790 | I |
| 17 Jan 2024 19:06 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 11 Dec 2023 | Purchase A | 1,000,000 | 5 | 5,000,000 | I |
| 12 Jan 2024 17:01 | SLDB | Solid Biosciences Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 11 Jan 2024 | Purchase | 904,160 | 5.53 | 5,000,005 | I |
| 13 Dec 2023 16:33 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 11 Dec 2023 | Purchase | 1,000,000 | 5 | 5,000,000 | I |
| 25 Sep 2023 16:30 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 21 Sep 2023 | Purchase | 191,309 | 3.83 | 732,713 | I |
| 25 Sep 2023 16:30 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 21 Sep 2023 | Purchase | 2,508,691 | 2.97 | 7,450,812 | I |
| 31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 29 Aug 2023 | Purchase | 3,750,000 | 6.2 | 23,250,000 | I |
| 22 Aug 2023 17:01 | ANTX | AN2 Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 18 Aug 2023 | Purchase | 1,777,778 | 9 | 16,000,002 | I |
| 25 Jul 2023 16:30 | ABOS | Acumen Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 21 Jul 2023 | Purchase | 5,161,290 | 7.75 | 39,999,998 | I |
| 21 Jul 2023 16:31 | JANX | Janux Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 19 Jul 2023 | Purchase | 495,008 | 12.46 | 6,167,800 | I |
| 07 Jul 2023 16:30 | BDTX | Black Diamond Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 05 Jul 2023 | Purchase | 935,850 | 5 | 4,679,250 | I |
| 30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 30 Mar 2023 | Purchase | 195,997 | 28.74 | 5,632,954 | I |
| 30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 29 Mar 2023 | Purchase | 66,369 | 29.38 | 1,949,921 | I |
| 30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 28 Mar 2023 | Purchase | 246,779 | 29.24 | 7,215,818 | I |
| 30 Mar 2023 17:00 | ETNB | 89bio Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 24 Mar 2023 | Purchase | 2,461,538 | 16.25 | 39,999,992 | I |
| 27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Mar 2023 | Purchase | 151,132 | 27.48 | 4,153,107 | I |
| 27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 24 Mar 2023 | Purchase | 192,335 | 26.87 | 5,168,041 | I |
| 27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 23 Mar 2023 | Purchase | 155,089 | 26.67 | 4,136,224 | I |
| 16 Feb 2023 17:04 | MLYS | Mineralys Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 14 Feb 2023 | Purchase | 1,118,400 | 16 | 17,894,400 | I |
| 16 Feb 2023 17:04 | MLYS | Mineralys Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 14 Feb 2023 | Purchase | 131,600 | 16 | 2,105,600 | I |
| 24 Jan 2023 16:30 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 20 Jan 2023 | Purchase | 1,923,076 | 13 | 24,999,988 | I |
| 10 Jan 2023 17:14 | HOWL | Werewolf Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 06 Jan 2023 | Purchase | 1,853,000 | 2.21 | 4,095,130 | I |
| 06 Jan 2023 16:39 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 04 Jan 2023 | Purchase | 58,369 | 7.7968 | 455,091 | I |
| 06 Jan 2023 16:39 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 04 Jan 2023 | Purchase | 122,334 | 7.0276 | 859,714 | I |
| 05 Jan 2023 16:43 | IMRA | IMARA Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 03 Jan 2023 | Purchase | 629,297 | 3.9982 | 2,516,055 | I |
| 29 Dec 2022 17:00 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 27 Dec 2022 | Purchase | 4,089 | 5.9941 | 24,510 | I |
| 21 Dec 2022 16:30 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 19 Dec 2022 | Purchase | 98,787 | 5.8997 | 582,814 | I |
| 16 Dec 2022 16:41 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 16 Dec 2022 | Purchase | 1,341,420 | 5.4195 | 7,269,826 | I |
| 16 Dec 2022 16:41 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 15 Dec 2022 | Purchase | 237,029 | 5.495 | 1,302,474 | I |
| 16 Dec 2022 16:41 | FULC | Fulcrum Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 14 Dec 2022 | Purchase | 824,600 | 5.4591 | 4,501,574 | I |
| 12 Dec 2022 16:30 | IMRA | IMARA Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 09 Dec 2022 | Purchase | 19,299 | 3.93 | 75,845 | I |
| 12 Dec 2022 16:30 | IMRA | IMARA Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 08 Dec 2022 | Purchase | 10,600 | 3.75 | 39,750 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)